Ghent University Academic Bibliography

Your filters: cql: author="Hogarty, Michael D" or (type any "bookEditor issueEditor" and editor="Hogarty, Michael D")

Add to list
- Conference Paper
- C3
MYCN activation in hTERT immortalized RPE cells as model for oncogene induced senescence

Sofia Zanotti, Bieke Decaesteker (UGent) , Suzanne Vanhauwaert (UGent) , Michael D Hogarty, Volodimir Olexiouk (UGent) , Kaat Durinck (UGent) , Winnok De Vos and Franki Speleman (UGent)

(2019) Belgian Society for Human Genetics, 19th Annual meeting, Abstracts.
Add to list
- Conference Paper
- C3
MYCN activation in hTERT immortalized RPE cells as a model for oncogene induced senescence

Sofia Zanotti, Marlies Verschuuren, Michael D Hogarty, Kaat Durinck (UGent) , Winnok De Vos and Franki Speleman (UGent)

(2018) Joint BSCDB/RBSM meeting: advanced microscopy in cell and development biology, Antwerpen.
Add to list
- Conference Paper
- C3
MYCN activation in hTERT immortalized RPE cells as model for oncogene induced senescence

Sofia Zanotti, Bieke Decaesteker (UGent) , Marlies Verschuuren, Michael D Hogarty, Kaat Durinck (UGent) , Winnok De Vos and Franki Speleman (UGent)

(2018) PhD research day, Abstracts.
Add to list
The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition

Laura Gamble, Stefania Purgato, Simone Di Giacomo, Amanda Russell, Paolo Pigini, Emanuele Valli, Lesley Ashton, Tom Van Maerken (UGent) , Jo Vandesompele (UGent) , Rogier Versteeg, et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
- Journal Article
- A1
- open access
Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt, Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2018) JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 110(10).
Add to list
- Conference Paper
- C3
Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt, Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2017) Cancer Genomics, 3rd EACR conference, Abstracts.
Add to list
- Conference Paper
- C3
Distal chromosome 6q deletion defines a group of ultra-high risk neuroblastoma patients

Pauline Depuydt, Valentina Boeva, Toby D Hocking, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, Matthias Fischer, Michael D Hogarty, et al.

(2016) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

Katleen De Preter (UGent) , Pieter Mestdagh (UGent) , Joëlle Vermeulen (UGent) , Fjoralba Zeka (UGent) , Alene Naranjo, Isabella Bray, Victoria Castel, Caifu Chen, Elzbieta Drozynska, Angelika Eggert, et al.

(2011) CLINICAL CANCER RESEARCH. 17(24). p.7684-7692
Add to list
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Joëlle Vermeulen (UGent) , Katleen De Preter (UGent) , Arlene Naranjo, Liesbeth Vercruysse (UGent) , Nadine Van Roy (UGent) , Jan Hellemans (UGent) , Katrien Swerts (UGent) , Sophie Bravo, Paolo Scaruffi, Gian Paolo Tonini, et al.

(2009) LANCET ONCOLOGY. 10(7). p.663-671

Academic Bibliography

MYCN activation in hTERT immortalized RPE cells as model for oncogene induced senescence

MYCN activation in hTERT immortalized RPE cells as a model for oncogene induced senescence

MYCN activation in hTERT immortalized RPE cells as model for oncogene induced senescence

The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition

Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Distal chromosome 6q deletion defines a group of ultra-high risk neuroblastoma patients

miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Contents

Support

Contact